Delta Investment Management’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-52,470
Closed -$427K 256
2025
Q1
$427K Hold
52,470
0.09% 143
2024
Q4
$672K Buy
52,470
+38,042
+264% +$449K 0.13% 100
2024
Q3
$155K Buy
+14,428
New +$136K 0.03% 237

Other funds holding RCEL

Delta Investment Management's RCEL Position: Q2 2025 in Review

Delta Investment Management sold out of Avita Medical (RCEL) in Q2 2025, closing a stake of 52,470 shares — an estimated $427K sold.

Delta Investment Management first reported a position in RCEL in Q3 2024 and held it in 3 quarters. The position peaked at $672K in Q4 2024. 80 funds tracked by Wall St. Rank hold RCEL as of Q2 2025.

  • Delta Investment Management reported no remaining Avita Medical position as of Q2 2025 after selling out during the quarter.
  • Delta Investment Management sold 52,470 Avita Medical shares in Q2 2025, an estimated $427K.
  • Delta Investment Management first reported a position in Avita Medical in Q3 2024 and held it in 3 quarters.
  • Delta Investment Management's Avita Medical position peaked at $672K in Q4 2024.
  • 80 funds tracked by Wall St. Rank held Avita Medical as of Q2 2025.

Based on Delta Investment Management's 13F filing for Q2 2025, filed 1 Aug 2025.